Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Espinoza Octavio reported 1 trade in Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 6, 2026
On Jun 30, 2026, Espinoza Octavio (Chief Financial Officer) reported 1 trade in Ligand Pharmaceuticals Incorporated shares at US$160.71 for US$2,732, leaving 27,696 shares. Filed Jul 6, 2026 (Form 4).
- Shares
- 17 shares
- Price
- US$160.71
- Value
- US$2,732
- Holding after
- 27,696 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Other | 17 | US$160.71 | 27,696 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Espinoza Octavio
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Espinoza Octavio · Aug 14, 2026
- Form 4 · Espinoza Octavio · May 28, 2026
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Haas Jason · Aug 14, 2026